138 related articles for article (PubMed ID: 15818296)
1. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Nachman SA; Lindsey JC; Moye J; Stanley KE; Johnson GM; Krogstad PA; Wiznia AA;
Pediatr Infect Dis J; 2005 Apr; 24(4):352-7. PubMed ID: 15818296
[TBL] [Abstract][Full Text] [Related]
2. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
3. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
4. Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy.
Nachman SA; Lindsey JC; Pelton S; Mofenson L; McIntosh K; Wiznia A; Stanley K; Yogev R
Arch Pediatr Adolesc Med; 2002 May; 156(5):497-503. PubMed ID: 11980557
[TBL] [Abstract][Full Text] [Related]
5. Impact of HAART on growth and hospitalization rates among HIV-infected children.
Diniz LM; Maia MM; Camargos LS; Amaral LC; Goulart EM; Pinto JA
J Pediatr (Rio J); 2011; 87(2):131-7. PubMed ID: 21412567
[TBL] [Abstract][Full Text] [Related]
6. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors.
Van Rossum AM; Gaakeer MI; Verweel S; Hartwig NG; Wolfs TF; Geelen SP; Lamberts SW; de Groot R
Pediatr Infect Dis J; 2003 Jan; 22(1):70-6. PubMed ID: 12544412
[TBL] [Abstract][Full Text] [Related]
7. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
Newell ML; Borja MC; Peckham C;
Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
[TBL] [Abstract][Full Text] [Related]
8. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children.
Miller TL; Mawn BE; Orav EJ; Wilk D; Weinberg GA; Nicchitta J; Furuta L; Cutroni R; McIntosh K; Burchett SK; Gorbach SL
Pediatrics; 2001 May; 107(5):E77. PubMed ID: 11331727
[TBL] [Abstract][Full Text] [Related]
9. Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.
Musoke PM; Mudiope P; Barlow-Mosha LN; Ajuna P; Bagenda D; Mubiru MM; Tylleskar T; Fowler MG
BMC Pediatr; 2010 Aug; 10():56. PubMed ID: 20691045
[TBL] [Abstract][Full Text] [Related]
10. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children.
Buchacz K; Cervia JS; Lindsey JC; Hughes MD; Seage GR; Dankner WM; Oleske JM; Moye J
Pediatrics; 2001 Oct; 108(4):E72. PubMed ID: 11581480
[TBL] [Abstract][Full Text] [Related]
11. Younger age at HAART initiation is associated with more rapid growth reconstitution.
McGrath CJ; Chung MH; Richardson BA; Benki-Nugent S; Warui D; John-Stewart GC
AIDS; 2011 Jan; 25(3):345-55. PubMed ID: 21102302
[TBL] [Abstract][Full Text] [Related]
12. Growth of HIV-Infected Children in the Early Stage of Antiretroviral Treatment: A Retrospective Cohort Study in China.
Hu R; Mu W; Sun X; Wu H; Pang L; Wang L; Zhao Q; Wu Y; Zhao D; Chen M; Ma Y; Zhang F
AIDS Patient Care STDS; 2016 Aug; 30(8):365-70. PubMed ID: 27509236
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
[TBL] [Abstract][Full Text] [Related]
15. Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy.
Bandyopadhyay A; Bhattacharyya S
Ann Trop Paediatr; 2008 Dec; 28(4):279-85. PubMed ID: 19021944
[TBL] [Abstract][Full Text] [Related]
16. Impact of highly active antiretroviral therapy on nutritional and immunologic status in HIV-infected children in the low-income country of Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
Nutrition; 2016 Jun; 32(6):667-73. PubMed ID: 26875999
[TBL] [Abstract][Full Text] [Related]
17. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda.
Kabue MM; Kekitiinwa A; Maganda A; Risser JM; Chan W; Kline MW
AIDS Patient Care STDS; 2008 Mar; 22(3):245-51. PubMed ID: 18298315
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire.
Fassinou P; Elenga N; Rouet F; Laguide R; Kouakoussui KA; Timite M; Blanche S; Msellati P
AIDS; 2004 Sep; 18(14):1905-13. PubMed ID: 15353976
[TBL] [Abstract][Full Text] [Related]
19. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
Banerjee T; Pensi T; Banerjee D; Grover G
Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
[TBL] [Abstract][Full Text] [Related]
20. The influence of nutritional status on the response to HAART in HIV-infected children in South Africa.
Naidoo R; Rennert W; Lung A; Naidoo K; McKerrow N
Pediatr Infect Dis J; 2010 Jun; 29(6):511-3. PubMed ID: 20179664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
